About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Il27ratm1Mak
targeted mutation 1, Tak Mak
MGI:3040914
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Il27ratm1Mak/Il27ratm1Mak B6.129P2-Il27ratm1Mak MGI:4943677
hm2
Il27ratm1Mak/Il27ratm1Mak involves: 129P2/OlaHsd * C57BL/6 MGI:4943708
cx3
Il10tm1Cgn/Il10tm1Cgn
Il27ratm1Mak/Il27ratm1Mak
involves: 129P2/OlaHsd * C57BL/6 MGI:4943707
cx4
Faslpr/Faslpr
Il27ratm1Mak/Il27ratm1Mak
MRL.Cg-Il27ratm1Mak Faslpr MGI:4943704


Genotype
MGI:4943677
hm1
Allelic
Composition
Il27ratm1Mak/Il27ratm1Mak
Genetic
Background
B6.129P2-Il27ratm1Mak
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il27ratm1Mak mutation (1 available); any Il27ra mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

immune system
• in vitro, mutant splenocytes show a slight increase in proliferation in response to stimulation with increasing concentrations of anti-CD3 or ConA
• purified mutant splenocytes show a relative increase in the number of cells in the S and G2+M phases of the cell cycle upon stimulation with anti-CD3 plus anti-CD28
• mutant splenocytes show normal dose-response kinetics in response to stimulation with anti-CD3 plus IL-12, but exhibit a higher proliferation rate than wild-type splenocytes at all but the highest dose of IL-12 upon co-stimulation with anti-CD28
• homozygotes display only an initial impairment of IFN-gamma production and induction of Th1 responses during the early stages of infection with an intracellular pathogen (J:89509)
• in a model of experimental autoimmune uveoretinitis, mice exhibit lower Th1 response compared with wild-type mice (J:116610)
• in the early phase of experimental autoimmune uveoretinitis
• in vitro, isolated mutant T cells produce decreased IFN-gamma levels upon primary stimulation with IL-12 plus ConA or anti-CD3 (J:89509)
• however, surprisingly, fully differentiated mutant Th1 cells subjected to a secondary stimulation with ConA produce wild-type levels of IFN-gamma (J:89509)
• in stimulated CD4+ T cells (J:116610)
• in Con A-stimulated liver mononuclear cells
• in Con A-stimulated liver mononuclear cells
• in the early phase, with lower Th1 response
• sub-retinal transplants fail to transfer experimental autoimmune uveoretinitis
• following infection with Myobacterium bovis bacillus Calmette-Guerin (BCG), homozygotes exhibit 8 times more liver granulomas than control littermates at 2 weeks post-infection
• although mutant granulomas are abnormally large and poorly differentiated, no differences in liver CFU number or liver damage are observed relative to similarly-infected wild-type mice
• although mutant splenocytes produce less IFN-gamma in response to anti-CD3 plus IL-12 than wild-type cells at day 2 post-infection, IFN-gamma production is restored to normal levels at at day 7, and serum IFN-gamma levels are comparable to wild-type levels at 2 weeks post-infection
• homozygotes exhibit increased susceptibility to Leishmania major infection, showing increased footpad swelling, more severe footpad ulcerations, and increased parasite burdern relative to control littermates
• infected homozygotes exhibit an abnormal initial Th1 response, as shown by impaired IFN-gamma production by popliteal lymph node CD4+ lymphocytes during the early phases of Leishmania major infection (at day 5 and 2 weeks post-infection), but not during the later phases (at 4 and 6 weeks post-infection) when both IFN-gamma expression and production levels are restored to wild-type levels
• in contrast, IL-4 expression is normal at day 5 but elevated at 2 weeks post-infection or later, concomittant with higher serum levels of IgG1 and IgE at 9 weeks post-infection, indicating a deviation toward a Th2 cytokine profile

liver/biliary system
• in Con A-treated mice

homeostasis/metabolism
• in the early phase of experimental autoimmune uveoretinitis
• at a low dose of Con A
• however, treatment with anti-IFN-gamma or anti-IL4 antibodies or depletion of NK cells lowers ALT levels
• mice exhibit increased sensitivity to Con A-induced liver injury with increased mortality and increased cytokine serum levels compared with wild-type mice
• mice treated with a low dose of Con A exhibit increased alanine transaminase serum levels and massive liver necrosis compared with similarly treated wild-type mice

hematopoietic system
N
• homozygotes display normal hematopoietic and lymphoid development relative to wild-type and heterozygous control mice
• in vitro, mutant splenocytes show a slight increase in proliferation in response to stimulation with increasing concentrations of anti-CD3 or ConA
• purified mutant splenocytes show a relative increase in the number of cells in the S and G2+M phases of the cell cycle upon stimulation with anti-CD3 plus anti-CD28
• mutant splenocytes show normal dose-response kinetics in response to stimulation with anti-CD3 plus IL-12, but exhibit a higher proliferation rate than wild-type splenocytes at all but the highest dose of IL-12 upon co-stimulation with anti-CD28
• homozygotes display only an initial impairment of IFN-gamma production and induction of Th1 responses during the early stages of infection with an intracellular pathogen (J:89509)
• in a model of experimental autoimmune uveoretinitis, mice exhibit lower Th1 response compared with wild-type mice (J:116610)

cellular
• in vitro, mutant splenocytes show a slight increase in proliferation in response to stimulation with increasing concentrations of anti-CD3 or ConA
• purified mutant splenocytes show a relative increase in the number of cells in the S and G2+M phases of the cell cycle upon stimulation with anti-CD3 plus anti-CD28
• mutant splenocytes show normal dose-response kinetics in response to stimulation with anti-CD3 plus IL-12, but exhibit a higher proliferation rate than wild-type splenocytes at all but the highest dose of IL-12 upon co-stimulation with anti-CD28




Genotype
MGI:4943708
hm2
Allelic
Composition
Il27ratm1Mak/Il27ratm1Mak
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il27ratm1Mak mutation (1 available); any Il27ra mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• in an E. coli-induced arthritis model, mice exhibit longer sustained inflammation and greater bone erosion compared with wild-type mice

skeleton
• in an E. coli-induced arthritis model, mice exhibit longer sustained inflammation and greater bone erosion compared with wild-type mice




Genotype
MGI:4943707
cx3
Allelic
Composition
Il10tm1Cgn/Il10tm1Cgn
Il27ratm1Mak/Il27ratm1Mak
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il10tm1Cgn mutation (15 available); any Il10 mutation (45 available)
Il27ratm1Mak mutation (1 available); any Il27ra mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• compared with Il10tm1Cgn homozygotes

immune system
• helminth-induced colitis compared with similarly treated Il10tm1Cgn homozygotes
• delayed and milder onset compared with Il10tm1Cgn homozygotes
• mice exhibit lower Th1 response compared with Il10tm1Cgn homozygotes
• helminth-infected mice exhibit a decrease in Th1 response and an increase in Th2 response compared with similarly treated Il10tm1Cgn homozygotes
• helminth-infected mice exhibit a decrease in Th1 response and an increase in Th2 response compared with similarly treated Il10tm1Cgn homozygotes
• in stimulated lymphocytes
• in mesenteric lymph node cells from helminth-infected mice compared with similarly treated Il10tm1Cgn homozygotes
• in mesenteric lymph node cells from helminth-infected mice compared with similarly treated Il10tm1Cgn homozygotes

digestive/alimentary system
• helminth-induced colitis compared with similarly treated Il10tm1Cgn homozygotes
• delayed and milder onset compared with Il10tm1Cgn homozygotes

hematopoietic system
• mice exhibit lower Th1 response compared with Il10tm1Cgn homozygotes
• helminth-infected mice exhibit a decrease in Th1 response and an increase in Th2 response compared with similarly treated Il10tm1Cgn homozygotes
• helminth-infected mice exhibit a decrease in Th1 response and an increase in Th2 response compared with similarly treated Il10tm1Cgn homozygotes




Genotype
MGI:4943704
cx4
Allelic
Composition
Faslpr/Faslpr
Il27ratm1Mak/Il27ratm1Mak
Genetic
Background
MRL.Cg-Il27ratm1Mak Faslpr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (82 available)
Il27ratm1Mak mutation (1 available); any Il27ra mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 10% of mice die by week 24 compared with 50% of Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice

immune system
N
• mice exhibit unaltered lymphocyte compartment compared with Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• mice exhibit increased IgG1 depositions in the kidneys compared with Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• IgG1 serum levels are increased compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• mice exhibit reduced IgG2a renal deposits and serum levels compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• Th2-type immune response is favored compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• 10-fold in stimulated CD4+ T cells compared with similarly treated Faslpr/Faslpr Il27ratm1Mak/Il27ra+ cells
• mice exhibit improved survival, creatinine serum level, blood urea nitrogen serum level, and renal injury compared with Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• mice develop membranous glomerulonephritis

renal/urinary system
• mice develop membranous glomerulonephritis

homeostasis/metabolism
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice

hematopoietic system
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• mice exhibit increased IgG1 depositions in the kidneys compared with Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• IgG1 serum levels are increased compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• mice exhibit reduced IgG2a renal deposits and serum levels compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• Th2-type immune response is favored compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
membranous glomerulonephritis DOID:10976 J:122148





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory